1 | A bill to be entitled |
2 | An act relating to Medicaid; providing waiver authority |
3 | for the Agency for Health Care Administration; providing |
4 | definitions; requiring managed care plans to provide a |
5 | wellness and disease management program for certain |
6 | Medicaid recipients participating in the waiver; requiring |
7 | managed care plans to provide pharmacy benefits; requiring |
8 | the agency to establish enhanced benefit coverage and |
9 | providing procedures therefor; establishing flexible |
10 | spending accounts and individual development accounts; |
11 | authorizing the agency to allow recipients to opt out of |
12 | Medicaid and purchase health care coverage through the |
13 | private insurance market; authorizing the agency to |
14 | establish health savings accounts and providing |
15 | requirements and procedures therefor; requiring the Office |
16 | of Program Policy Analysis and Government Accountability |
17 | to study and issue a report on the opt-out program; |
18 | requiring the agency to apply and enforce certain |
19 | provisions of law relating to Medicaid fraud and abuse; |
20 | providing penalties; providing applicability; granting |
21 | rulemaking authority to the agency; requiring the |
22 | Legislative Budget Commission to approve the waiver |
23 | application; requiring legislative authority to implement |
24 | the waiver; providing for future review and repeal of the |
25 | act; providing an effective date. |
26 |
|
27 | Be It Enacted by the Legislature of the State of Florida: |
28 |
|
29 | Section 1. Medicaid reform; eligibility determination; |
30 | services.-- |
31 | (1) WAIVER AUTHORITY.--Notwithstanding any other law to |
32 | the contrary, the Agency for Health Care Administration is |
33 | authorized to seek an experimental, pilot, or demonstration |
34 | project waiver, pursuant to s. 1115 of the Social Security Act, |
35 | to reform Florida's Medicaid program in urban and rural |
36 | demonstration sites contingent on federal approval to preserve |
37 | the upper-payment-limit funding method and the disproportionate |
38 | share program pursuant to chapter 409, Florida Statutes. |
39 | (2) DEFINITIONS.--As used in this section, the term: |
40 | (a) "Agency" means the Agency for Health Care |
41 | Administration. |
42 | (b) "Enhanced benefit coverage" means additional health |
43 | care services or alternative health care coverage which can be |
44 | purchased by qualified recipients. |
45 | (c) "Flexible spending account" means an account that |
46 | encourages consumer ownership and management of resources |
47 | available for enhanced benefit coverage, wellness activities, |
48 | preventive services, and other services to improve the health of |
49 | the recipient. |
50 | (d) "Health savings account" means an account under which |
51 | an individual covered by a high-deductible health plan may |
52 | contribute funds to pay for qualified medical expenses. |
53 | (e) "Individual development account" means a dedicated |
54 | savings account that is designed to encourage and enable a |
55 | recipient to build assets in order to purchase health-related |
56 | services or health-related products. |
57 | (f) "Managed care plan" means a health maintenance |
58 | organization authorized under part I of chapter 641, Florida |
59 | Statutes; an entity under part II or part III of chapter 641, |
60 | chapter 627, chapter 636, or s. 409.912, Florida Statutes; a |
61 | licensed mental health provider under chapter 394, Florida |
62 | Statutes; a licensed substance abuse provider under chapter 397, |
63 | Florida Statutes; a certified administrator under chapter 626, |
64 | Florida Statutes; or a hospital under chapter 395, Florida |
65 | Statutes, certified by the agency to operate as a managed care |
66 | plan. |
67 | (g) "Medicaid opt-out option" means a program that allows |
68 | a recipient to purchase health care insurance through the |
69 | private insurance market or an employer-sponsored insurer |
70 | instead of through a Medicaid-certified plan. |
71 | (h) "Shall" means the agency must include the provision of |
72 | a subsection, paragraph, or subparagraph as delineated in this |
73 | section in the waiver application and implement the provision to |
74 | the extent allowed in the waiver demonstration sites by the |
75 | Centers for Medicare and Medicaid Services and as approved by |
76 | the Legislature pursuant to this section. |
77 | (3) MANAGED CARE PLANS; WELLNESS AND DISEASE |
78 | MANAGEMENT.--The agency shall develop a capitated system of care |
79 | that promotes choice and competition. |
80 | (a) The agency shall require any plan under this section |
81 | to establish performance objectives to encourage wellness |
82 | behaviors or minimize the exposure of recipients to the need for |
83 | acute inpatient, custodial, and other institutional and long- |
84 | term care placement and the inappropriate or unnecessary |
85 | utilization of high-cost services. |
86 | (b) The agency shall require plans to provide a wellness |
87 | or disease management program for certain Medicaid recipients |
88 | participating in the waiver. At a minimum, the agency shall |
89 | require plans to develop at least four disease management |
90 | programs for recipients from the following list of diseases and |
91 | conditions: |
92 | 1. Diabetes. |
93 | 2. Asthma. |
94 | 3. HIV/AIDS. |
95 | 4. Hemophilia. |
96 | 5. End-stage renal disease. |
97 | 6. Congestive heart failure. |
98 | 7. Chronic obstructive pulmonary disease. |
99 | 8. Autoimmune disorders. |
100 | 9. Obesity. |
101 | 10. Smoking. |
102 | 11. Hypertension. |
103 | 12. Coronary artery disease. |
104 | 13. Chronic kidney disease. |
105 | 14. Chronic pain. |
106 | (c) The agency shall require a plan to develop appropriate |
107 | disease management protocols and develop procedures for |
108 | implementing those protocols, and determine the procedure for |
109 | providing disease management services to plan enrollees. The |
110 | agency is authorized to allow a plan to contract separately with |
111 | another entity for disease management services or provide |
112 | disease management services directly through the plan. |
113 | (d) The agency shall provide oversight to ensure that the |
114 | service network provides the contractually agreed upon level of |
115 | service. |
116 | (e) The agency may establish performance contracts that |
117 | reward a plan when measurable operational targets in both |
118 | participation and clinical outcomes are reached or exceeded by |
119 | the plan. |
120 | (f) The agency shall establish performance contracts that |
121 | penalize a plan when measurable operational targets for both |
122 | participation and clinical outcomes are not reached by the plan. |
123 | (g) The agency shall develop oversight requirements and |
124 | procedures to ensure that plans utilize standardized methods and |
125 | clinical protocols for determining compliance with a wellness or |
126 | disease management plan. |
127 | (4) PHARMACY BENEFITS.-- |
128 | (a) The agency shall require plans to provide pharmacy |
129 | benefits and include pharmacy benefits as part of the capitation |
130 | risk structure to enable a plan to coordinate and fully manage |
131 | all aspects of patient care as part of the plan or through a |
132 | pharmacy benefits manager. |
133 | (b) The agency may set standards for pharmacy benefits for |
134 | managed care plans and health insurance plans participating in |
135 | the Medicaid opt-out option. |
136 | (c) The agency may set appropriate medication guidelines, |
137 | including guidelines for copayments. |
138 | (d) The agency shall facilitate the establishment of a |
139 | Florida managed care plan purchasing alliance. The purpose of |
140 | the alliance is to form agreements among participating plans to |
141 | purchase pharmaceuticals at a discount, to achieve rebates, or |
142 | to receive best market price adjustments. Participation in the |
143 | Florida managed care plan purchasing alliance shall be |
144 | voluntary. |
145 | (e) Each plan shall implement a pharmacy fraud, waste, and |
146 | abuse initiative that may include a surety bond or letter of |
147 | credit requirement for participating pharmacies, enhanced |
148 | provider auditing practices, the use of additional fraud and |
149 | abuse software, recipient management programs for recipients |
150 | inappropriately using their benefits, and other measures to |
151 | reduce provider and recipient fraud, waste, and abuse. The |
152 | initiative shall address enforcement efforts to reduce the |
153 | number and use of counterfeit prescriptions. |
154 | (f) The agency shall require plans to report incidences of |
155 | pharmacy fraud and abuse and establish procedures for receiving |
156 | and investigating fraud and abuse reports from plans in the |
157 | demonstration sites. Plans must report instances of fraud and |
158 | abuse pursuant to chapter 641, Florida Statutes. |
159 | (5) ENHANCED BENEFIT COVERAGE.-- |
160 | (a) The agency shall establish enhanced benefit coverage |
161 | and a methodology to fund the enhanced benefit coverage. |
162 | (b) A recipient who complies with the objectives of a |
163 | wellness or disease management plan, as determined by the plan, |
164 | shall have access to the enhanced benefit coverage for the |
165 | purpose of purchasing or securing health-care services or |
166 | health-care products. |
167 | (c) The agency shall establish flexible spending accounts |
168 | or similar accounts for recipients as approved in the waiver to |
169 | be administered by the agency or by a managed care plan. The |
170 | agency shall make deposits to a recipient's flexible spending |
171 | account contingent on compliance with a wellness plan or a |
172 | disease management plan. |
173 | (d) The purpose of the flexible spending accounts is to |
174 | allow waiver recipients to accumulate funds up to a maximum of |
175 | $1,000 for purposes of activities allowed by federal regulations |
176 | or as approved in the waiver. |
177 | (e) The agency may allow a plan to establish other |
178 | additional reward systems for compliance with a wellness or |
179 | disease management objective that are supplemental to the |
180 | enhanced benefit coverage. |
181 | (f) The agency shall establish individual development |
182 | accounts or similar account for recipients as approved in the |
183 | waiver. The agency shall make deposits into a recipient's |
184 | individual development account contingent upon compliance with a |
185 | wellness or a disease management plan. |
186 | (g) The purpose of an individual development account is to |
187 | allow waiver recipients to accumulate funds up to a maximum of |
188 | $1,000 for purposes of activities allowed by federal regulations |
189 | or as approved in the waiver. |
190 | (h) A recipient shall choose to participate in a flexible |
191 | spending account or an individual development account to |
192 | accumulate funds pursuant to the provisions of this section. |
193 | (i) It is the intent of the Legislature that flexible |
194 | spending accounts and individual development accounts encourage |
195 | consumer ownership and management of resources for wellness |
196 | activities, preventive services, and other services to improve |
197 | the health of the recipient. |
198 | (j) The agency shall develop standards and oversight |
199 | procedures to monitor access to enhanced services, the use of |
200 | flexible spending accounts, and the use of individual |
201 | development accounts as approved by the waiver. |
202 | (k) It is the intent of the Legislature that the agency |
203 | develop an electronic benefit transfer system for the |
204 | distribution of enhanced benefit funds earned by the recipient. |
205 | (l) The agency shall establish or contract for an |
206 | administrative structure to manage the enhanced benefit |
207 | coverage. |
208 | (6) MEDICAID OPT-OUT OPTION.-- |
209 | (a) The agency may allow recipients to purchase health |
210 | care coverage through the private insurance market instead of |
211 | through a Medicaid-certified plan for recipients who are |
212 | enrolled in a plan that meets requirements established by the |
213 | agency in consultation with the Office of Insurance Regulation. |
214 | (b) A recipient who chooses the Medicaid opt-out option |
215 | shall remain in the opt-out program for at least 1 year or until |
216 | the recipient no longer has access to employer-sponsored |
217 | insurance, until the employer's open enrollment period for a |
218 | person who opts out in order to participate in employer- |
219 | sponsored coverage, or until the person is no longer eligible |
220 | for Medicaid, whichever time period is shorter. |
221 | (c) The agency may establish other criteria and procedures |
222 | to allow recipients who are not satisfied with the insurance |
223 | plan to redirect the defined contribution allocated to the |
224 | recipient to a managed care plan. |
225 | (d) The agency may allow recipients to opt out of Medicaid |
226 | and establish health savings accounts. Recipients who choose to |
227 | opt out of Medicaid and establish health savings accounts must |
228 | purchase catastrophic insurance coverage. |
229 | (e) The agency may allow a recipient who chooses to |
230 | participate in the opt-out option to direct the defined |
231 | contribution allocated to the recipient to pay the recipient's |
232 | portion of the premiums for employer-sponsored or direct health |
233 | care coverage available to the recipient in his or her place of |
234 | employment. Notwithstanding any other provision of this section, |
235 | coverage, cost sharing, and any other component of employer- |
236 | sponsored health insurance shall be governed by applicable state |
237 | and federal laws. |
238 | (f) The agency, in consultation with the Office of |
239 | Insurance Regulation, shall: |
240 | 1. Determine which Medicaid recipients may participate in |
241 | the opt-out option on a voluntary basis. |
242 | 2. Determine the comprehensive services and benefits to be |
243 | included in the opt-out option consistent with the mandatory |
244 | services specified in s. 409.905, Florida Statutes, the |
245 | behavioral health services specified in s. 409.906(8), Florida |
246 | Statutes, and the pharmacy services specified in s. 409.906(20), |
247 | Florida Statutes, and may develop additional specifications for |
248 | the insurance coverage. |
249 | 3. Determine the type of plans currently licensed under |
250 | state law that are suitable to serve the Medicaid opt-out |
251 | population. |
252 | 4. Establish oversight, fraud and abuse, administrative, |
253 | and accounting procedures as recommended by the Office of |
254 | Insurance Regulation for the operation of the opt-out option. |
255 | 5. Implement oversight and monitoring activities, |
256 | including, but not limited to, administrative and financial |
257 | monitoring, which shall be conducted by the Office of Insurance |
258 | Regulation. |
259 | 6. Include the results of oversight and monitoring |
260 | activities in the choice counseling process to allow individuals |
261 | to review the information before making a choice to enroll in a |
262 | plan. |
263 | (g) The agency may: |
264 | 1. Enter into contracts with qualified third parties, |
265 | private or public, for any service necessary to carry out the |
266 | purposes of the opt-out option. |
267 | 2. Take any legal action on behalf of the recipient |
268 | against any insurance company to enforce compliance with |
269 | coverage requirements. |
270 | (h) Two years after the implementation of the waiver, the |
271 | Office of Program Policy Analysis and Government Accountability |
272 | shall conduct studies and analyses related to the opt-out |
273 | option, including examining the type of health care benefits |
274 | provided, utilization, costs, quality, and efforts to address |
275 | occurrences of fraud and abuse. A copy of the report shall be |
276 | provided to the legislative committees having jurisdiction over |
277 | the opt-out option. |
278 | (7) FRAUD AND ABUSE.-- |
279 | (a) To minimize the risk of Medicaid fraud and abuse, the |
280 | agency shall ensure that applicable provisions of chapters 409, |
281 | 414, 626, 641, and 932, Florida Statutes, relating to Medicaid |
282 | fraud and abuse, are applied and enforced at the waiver |
283 | demonstration sites. |
284 | (b) Providers must have the necessary certification, |
285 | license, and credentials as required by law and waiver |
286 | requirements. |
287 | (c) When a plan is not a fully indemnified insurance |
288 | program under chapter 624, chapter 627, chapter 636, or chapter |
289 | 641, Florida Statutes, the plan must meet financial solvency |
290 | requirements as specified in chapter 641, Florida Statutes, and |
291 | as determined by the agency in the certification process, in |
292 | consultation with the Office of Insurance Regulation. |
293 | (d) The agency shall ensure that the plan is in compliance |
294 | with the provisions of s. 409.912(21) and (22), Florida |
295 | Statutes. |
296 | (e) The agency shall require each plan to establish |
297 | program integrity functions and activities to reduce the |
298 | incidence of fraud and abuse. Plans must report instances of |
299 | fraud and abuse pursuant to chapter 641, Florida Statutes. |
300 | (f) The agency shall establish a unit within the Office of |
301 | Medicaid Program Integrity dedicated to fraud and abuse |
302 | prevention, mitigation, and intervention in the waiver |
303 | demonstration sites. |
304 | (g)1. The agency shall require all contractors in the |
305 | managed care plan to report all instances of suspected fraud and |
306 | abuse. A failure to report instances of suspected fraud and |
307 | abuse is a violation of law and subject to the penalties |
308 | provided by law. |
309 | 2. An instance of fraud and abuse in the managed care |
310 | plan, including, but not limited to, defrauding the state health |
311 | care benefit program by misrepresentation of fact in reports, |
312 | claims, certifications, enrollment claims, demographic |
313 | statistics, and encounter data; the misrepresentation of the |
314 | qualifications of persons rendering health care and ancillary |
315 | services; bribery and false statements relating to the delivery |
316 | of health care; unfair and deceptive marketing practices; and |
317 | managed care false claims actions, is a violation of law and |
318 | subject to the penalties provided by law. |
319 | 3. The agency shall require that all contractors make all |
320 | files and relevant billing and claims data accessible to state |
321 | regulators and investigators and that all such data be linked |
322 | onto a unified system for seamless reviews and investigations. |
323 | (8) APPLICABILITY.-- |
324 | (a) The provisions of this section apply only to the |
325 | waiver demonstration sites approved by the Legislature. |
326 | (b) The Legislature authorizes the Agency for Health Care |
327 | Administration to apply and enforce any provision of law not |
328 | referenced in this section to ensure the safety, quality, and |
329 | integrity of the waiver. |
330 | (c) In any circumstance when the provisions of chapter |
331 | 409, Florida Statutes, conflict with this section, this section |
332 | shall prevail. |
333 | (9) RULEMAKING AUTHORITY.--The Agency for Health Care |
334 | Administration is authorized to adopt rules to implement the |
335 | provisions of this section. |
336 | (10) WAIVER APPLICATION.--The agency shall submit the |
337 | waiver application pursuant to this section to the Legislative |
338 | Budget Commission for approval prior to submitting the waiver |
339 | application to the Centers for Medicare and Medicaid Services. |
340 | (11) IMPLEMENTATION.-- |
341 | (a) This section does not authorize the agency to |
342 | implement any provision of the s. 1115 of the Social Security |
343 | Act experimental, pilot, or demonstration program waiver to |
344 | reform the state Medicaid program. |
345 | (b) Upon approval of a waiver by the Centers for Medicare |
346 | and Medicaid Services, the agency shall report the provisions |
347 | and structure of the approved waiver and any deviations from |
348 | this section to the Legislature. The agency shall implement the |
349 | waiver after authority to implement the waiver is granted by the |
350 | Legislature. |
351 | (12) REVIEW AND REPEAL.--This section shall stand repealed |
352 | on July 1, 2010, unless reviewed and saved from repeal through |
353 | reenactment by the Legislature. |
354 | Section 2. This act shall take effect July 1, 2005. |